Clearstead Advisors, LLC Amgen Inc Transaction History

Clearstead Advisors, LLC

$6.31 Billion
Q3 2024

A detailed history of Clearstead Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Clearstead Advisors, LLC holds 35,520 shares of AMGN stock, worth $9.39 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

35,520

Previous 32,830 8.19%

Holding current value

$9.39 Million

Previous $10.3 Million 11.57%

% of portfolio

0.18%

Previous 0.18%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$309.38 - $337.38 $832,232 - $907,552	2,690 Added 8.19%	35,520 $11.4 Million
Q2 2024 Aug 09, 2024	BUY	$262.75 - $319.31 $4.09 Million - $4.97 Million	15,570 Added 90.21%	32,830 $10.3 Million
Q1 2024 May 14, 2024	SELL	$268.87 - $324.56 $125,024 - $150,920	-465 Reduced 2.62%	17,260 $4.91 Million
Q4 2023 Feb 12, 2024	BUY	$255.7 - $288.46 $6,903 - $7,788	27 Added 0.15%	17,725 $5.11 Million
Q3 2023 Nov 13, 2023	SELL	$218.65 - $271.46 $59,035 - $73,294	-270 Reduced 1.5%	17,698 $4.76 Million
Q3 2023 Nov 07, 2023	BUY	$218.65 - $271.46 $207,936 - $258,158	951 Added 5.59%	17,968 $4.83 Million
Q2 2023 Aug 07, 2023	BUY	$214.27 - $253.37 $205,484 - $242,981	959 Added 5.97%	17,017 $3.78 Million
Q1 2023 May 09, 2023	SELL	$225.79 - $275.2 $49,673 - $60,544	-220 Reduced 1.35%	16,058 $3.88 Million
Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $106,269 - $135,028	-464 Reduced 2.77%	16,278 $4.28 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $34,117 - $38,478	-152 Reduced 0.9%	16,742 $3.77 Million
Q2 2022 Aug 12, 2022	BUY	$230.71 - $256.74 $30,453 - $33,889	132 Added 0.79%	16,894 $4.11 Million
Q1 2022 May 04, 2022	BUY	$219.27 - $242.57 $349,077 - $386,171	1,592 Added 10.49%	16,762 $4.05 Million
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $1,789 - $2,048	9 Added 0.06%	15,170 $3.41 Million
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $38,845 - $45,512	183 Added 1.22%	15,161 $3.22 Million
Q2 2021 Aug 12, 2021	BUY	$233.58 - $259.14 $17,518 - $19,435	75 Added 0.5%	14,978 $3.65 Million
Q1 2021 May 14, 2021	BUY	$221.91 - $258.6 $493,749 - $575,385	2,225 Added 17.55%	14,903 $3.71 Million
Q4 2020 Feb 11, 2021	BUY	$216.38 - $257.67 $44,790 - $53,337	207 Added 1.66%	12,678 $2.92 Million
Q3 2020 Nov 12, 2020	SELL	$234.65 - $260.95 $37,309 - $41,491	-159 Reduced 1.26%	12,471 $3.17 Million
Q2 2020 Aug 11, 2020	BUY	$197.81 - $242.74 $23,341 - $28,643	118 Added 0.94%	12,630 $2.98 Million
Q4 2019 Feb 11, 2020	BUY	$189.21 - $243.2 $308,223 - $396,172	1,629 Added 14.97%	12,512 $3.02 Million
Q3 2019 Nov 12, 2019	SELL	$174.11 - $208.62 $3,308 - $3,963	-19 Reduced 0.17%	10,883 $2.11 Million
Q2 2019 Aug 08, 2019	BUY	$166.7 - $195.41 $97,519 - $114,314	585 Added 5.67%	10,902 $2.01 Million
Q1 2019 May 14, 2019	BUY	$180.87 - $203.88 $66,921 - $75,435	370 Added 3.72%	10,317 $1.96 Million
Q4 2018 Feb 11, 2019	SELL	$178.4 - $208.25 $15,877 - $18,534	-89 Reduced 0.89%	9,947 $1.94 Million
Q3 2018 Nov 13, 2018	BUY	$185.29 - $208.89 $37,058 - $41,778	200 Added 2.03%	10,036 $2.08 Million
Q2 2018 Aug 07, 2018	BUY	$166.05 - $186.51 $50,645 - $56,885	305 Added 3.2%	9,836 $1.82 Million
Q4 2017 Feb 09, 2018	SELL	$168.79 - $188.59 $139,251 - $155,586	-825 Reduced 7.97%	9,531 $1.66 Million
Q3 2017 Nov 09, 2017	BUY	$167.29 - $191.0 $1.73 Million - $1.98 Million	10,356	10,356 $1.93 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearstead Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearstead Advisors, LLC with notifications on news.

Account

Clearstead Advisors, LLC Amgen Inc Transaction History